Safety, Pharmacokinetic and Pharmacodynamic Study of the CDK 4/6 Inhibitor G1T28-1

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This first-in-human (FIH) study will provide the first safety, PK, and PD data of G1T28-1 in humans and will allow further development of G1T28 1 in patients with cancer to reduce chemotherapy-induced myelosuppression.
Epistemonikos ID: d4e88e462fdc2c85fca4557ab30b68bb73494893
First added on: May 12, 2024